Home > Drug Search >
  • company_query: Altiris Therapeutics
  •   > 
Drug Filter
Category:
chemistry (22) biology (1)
Status:
NDA Filing (1) Phase Ⅲ (6) Phase Ⅱ (9) Phase Ⅰ (7)
Clinical Stage:
Pending (4) Active (18) Discontinued (1)
Indication:
Acute coronary syndrome (ACS) (1) Allergic conjunctivitis (1) Allergic rhinitis (AR) (1) Asthma (1) Atherosclerosis (1) Atopic dermatitis (1) Bladder cancer (1) Breast cancer (2) Cerebrovascular diseases (1) Gastric cancer (1) HBV infection (1) HCV infection (1) Hepatocellular carcinoma (HCC) (1) HIV infection (2) Lymphoma (1) Major depressive disorder (MDD) (1) Malignancies (1) Non small cell lung cancer (NSCLC) (3) Pancreatic cancer (2) Schizophrenia (1) Solid tumours (2) Type 2 diabetes (1) Head and neck cancer (1) Renal carcinoma (2) Glioblastoma (1) Prediabetes (1) Hot flushes (1) Alopecia (1) Neurological disease (2) Central nervous system tumors (1) Cardiovascular disorders (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top